Related Articles

Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.

Ann Thorac Surg. 2013 Mar;95(3):987-92

Authors: Zhong C, Yao F, Zhao H

Abstract
BACKGROUND: We compared the surgical outcomes in patients with clinical N0 and pathologic N2 (cN0-pN2) non-small cell lung cancer (NSCLC) who underwent video-assisted thoracoscopic surgery (VATS) lobectomy and open thoracotomy to evaluate the role of VATS lobectomy for cN0-pN2 disease.
METHODS: Between March 2006 and August 2011, 1,456 patients with clinical N0 NSCLC disease underwent lobectomy with systematic node dissection (SND) at Shanghai Chest Hospital. Of those patients, 157 were shown to have cN0-pN2 NSCLC. Of those, 67 patients underwent VATS lobectomy, and 90 patients underwent open lobectomy. SND was performed in all 157 patients. Clinicopathologic factors, local recurrence rates, and survival rates were compared.
RESULTS: The two groups were similar in age, sex, and pulmonary function. The VATS approach was associated with significantly shorter chest tube duration and postoperative stay than was the thoracotomy approach. Operative mortality, morbidity, and recurrence did not differ between the two groups. There was no significant difference between the two types of operation in numbers of total lymph nodes removed (17.4 ± 6.1 in the VATS group vs 18.1 ± 7.2 in the open group, p = 0.78) and mediastinal lymph nodes removed (11.7 ± 5.6 in the VATS group vs 12.0 ± 5.1 in the open group, p = 0.84). Similarly, the two groups were not significantly different with regard to stations of total lymph nodes removed (7.6 ± 1.9 in the VATS group vs 7.8 ± 2.3 in the open group, p = 0.81) and mediastinal lymph nodes removed (4.5 ± 1.1 in the VATS group vs 4.7 ± 1.3 in the open group, p = 0.71). The rates of overall survival and disease-free 5-year survival were not significantly different between the two groups.
CONCLUSIONS: The clinical outcomes of thoracoscopic lobectomy were comparable to those of thoracotomy for patients with cN0-pN2 NSCLC. Single-station N2 is a good prognostic factor for disease-free survival in these patients.

PMID: 23261117 [PubMed - indexed for MEDLINE]

Related Articles

Role of flexible bronchoscopic cryotechnology in diagnosing endobronchial masses.

Ann Thorac Surg. 2013 Mar;95(3):982-6

Authors: Chou CL, Wang CW, Lin SM, Fang YF, Yu CT, Chen HC, Kuo CH, Hsieh MH, Chung FT

Abstract
BACKGROUND: Endobronchial masses obstruct the central airway, and cryotechnology is reportedly a feasible means of managing such masses. However, few reports have explored the role of cryotechnology in diagnosing endobronchial masses.
METHODS: All endobronchial masses were sampled for pathologic diagnosis by forceps biopsy and cryotechnology, performed during flexible bronchoscopy. The diagnostic accuracy of forceps biopsy and that of cryotherapy were compared by the χ(2) test, and the obtained specimen sizes were compared by the t test.
RESULTS: Between 2007 and 2011, 75 patients with a median age of 64 years (interquartile range [IQR], 49-76; 48 men; 27 women; and 52 smokers [69.3%]) were diagnosed with endobronchial masses. The sites of these masses included the trachea (n = 17), left main bronchus (n = 16), right main bronchus (n = 11), right upper lobe bronchus (n = 11), right intermediate bronchus (n = 8), right lower lobe bronchus (n = 4), left upper lobe bronchus (n = 3), left lower lobe bronchus (n = 3), and right middle lobe bronchus (n = 2). Fifty-nine lesions were malignant, and 16 were benign. Lung squamous cell carcinoma (n = 23) was the leading cause of malignancy, and endobronchial tuberculosis (n = 9) was the most common benign disease. The diagnostic accuracy of cryotechnology was significantly higher than that of forceps biopsy (100% vs 69.3%, p < 0.0001). The specimen size obtained by cryotechnology was also significantly larger than that obtained by forceps biopsy (13.8 ± vs 1.9 ± 0.6 mm, p < 0.0001).
CONCLUSIONS: The current study supports the view that cryotechnology is a good tool for diagnosing endobronchial masses. Cryotechnology also provides a better diagnostic specimen and has greater diagnostic accuracy than traditional forceps biopsy.

PMID: 23352294 [PubMed - indexed for MEDLINE]

Related Articles

A new method to predict postoperative lung function: quantitative breath sound measurements.

Ann Thorac Surg. 2013 Mar;95(3):968-75

Authors: Detterbeck F, Gat M, Miller D, Force S, Chin C, Fernando H, Sonett J, Morice R

Abstract
BACKGROUND: Currently, predicted postoperative (PPO) lung function (forced expiratory volume in 1 second [PPO-FEV(1)] and diffusion capacity of the lung for carbon monoxide [PPO-Dlco]) estimated from spirometry and regional perfusion is used to select patients for lung resection. Vibration response imaging (VRI) analyzes lung sounds and quantifies regional acoustic energy. Single-center studies suggest that this noninvasive, radiation-free method of quantifying lung function is comparable to the reference standard.
METHODS: A prospective, multiinstitutional United States study comparing VRI with perfusion in patient assessment for lung resection enrolled 163 patients, with 135 currently available for analysis. PPO values were calculated by subtracting the fraction of segments to be resected in a lung (113 lobectomies, 20 pneumonectomies) multiplied by the percentage of acoustic energy (VRI) or perfusion of that lung. We compared the two methods with each other, with actual postoperative pulmonary function tests, and the rate of complications as predicted by PPO values above or below 40%.
RESULTS: Good agreement was found between calculated estimations of postoperative lung function using VRI and perfusion measurements (PPO-FEV(1)%: r = 0.95; -8% to 11.5%; PPO-Dlco: r = 0.97; -6.6% to 9.5%), although larger discrepancies were noted between the actual VRI and perfusion measurements (-17 to 24). The VRI and perfusion methods provided excellent agreement in categorization of patients into low or elevated risk based on PPO values of above or below 40% (95% for PPO-FEV(1)%; 94% for PPO-Dlco) and similar correlations with actual postoperative values (r = 0.74 and r = 0.67 for FEV(1); r = 0.72 and r = 0.67 for Dlco).
CONCLUSIONS: VRI may offer a simple, noninvasive, and radiation-free alternative to lung scintigraphy for predicting postoperative lung function in patients with lung malignancies.

PMID: 23369350 [PubMed - indexed for MEDLINE]

Related Articles

History of multiple previous malignancies should not be a contraindication to the surgical resection of lung cancer.

Ann Thorac Surg. 2013 Mar;95(3):1000-5

Authors: Pagès PB, Mordant P, Grand B, Badia A, Foucault C, Dujon A, Le Pimpec-Barthes F, Riquet M

Abstract
BACKGROUND: Patients with a history of previous malignancy are often encountered in a discussion of surgical resection of non-small-cell lung cancer (NSCLC). The outcome of patients with 2 or more previous cancers remains unknown.
METHODS: We performed a retrospective study including all patients undergoing resection for NSCLC from January 1980 to December 2009 at 2 French centers. We then compared the survival of patients without a history of another cancer (group 1), those with a history of a single malignancy (group 2), and those with a history of 2 or more previous malignancies (group 3).
RESULTS: There were 5,846 patients: 4,603 (78%) in group 1, 1,147 (20%) in group 2, and 96 (2%) in group 3. The proportion of patients included in group 3 increased from 0.3% to 3% over 3 decades. Compared with groups 1 and 2, group 3 was associated with older age, a larger proportion of women, earlier tumor stage, less induction therapy, and fewer pneumonectomies. Despite this, postoperative complications and mortality were similar in groups 2 and 3, and higher than in group 1. Five-year survival rates were 44.6%, 35.1%, and 23.6% in groups 1, 2, and 3, respectively (p < 0.000001 for comparison between 3 groups; p = 0.18 for comparison between groups 2 and 3). In multivariate analysis, male sex, higher T stage, higher N stage, incomplete resection, and study group were significant predictors of adverse prognosis.
CONCLUSIONS: Despite earlier diagnosis and acceptable long-term survival, patients operated on for NSCLC after 2 or 3 previous malignancies carried a worse prognosis than did those undergoing operation after 1 malignancy or if there was no previous diagnosis of cancer.

PMID: 23375734 [PubMed - indexed for MEDLINE]